T1	Participants 46 110	patients with retinitis pigmentosa receiving vitamin A treatment
T2	Participants 328 387	208 patients with retinitis pigmentosa, aged 18 to 55 years
T3	Participants 622 718	Seventy percent of the patients in each group were taking vitamin A, 15 000 IU/d, prior to entry
T4	Participants 2397 2440	patients on vitamin A for at least 2 years,
